Jasper Therapeutics, Inc. <JSPR.O>: Piper Sandler initiates coverage with overweight rating; target price $2
JSPR•Related News
Realty Income prices upsized USD 875 million convertible senior notes offering
O•
Lightpath Technologies Inc <LPTH.O>: Piper Sandler Initiates Coverage With Overweight Rating; Target Price $15
LPTH•
Hedge funds upped short AI bets in July, Hazeltree says
SOXX•
BUZZ-CoreWeave jumps on quarterly beat, capex forecast hike on AI demand
CRWV•
Nikkei ends higher on chipmakers' boost ahead of US inflation data
EWJ•